These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

382 related items for PubMed ID: 20639564

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Second-line antiretroviral therapy in resource-limited settings: the experience of Médecins Sans Frontières.
    Pujades-Rodríguez M, O'Brien D, Humblet P, Calmy A.
    AIDS; 2008 Jul 11; 22(11):1305-12. PubMed ID: 18580610
    [Abstract] [Full Text] [Related]

  • 4. Profile of HIV-infected patients receiving second-line antiretroviral therapy in a resource-limited setting in Nigeria.
    Onyedum CC, Iroezindu MO, Chukwuka CJ, Anyaene CE, Obi FI, Young EE.
    Trans R Soc Trop Med Hyg; 2013 Oct 11; 107(10):608-14. PubMed ID: 23959002
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Effectiveness of boosted protease inhibitor-based regimens in HIV type 1-infected patients who experienced virological failure with NNRTI-based antiretroviral therapy in a resource-limited setting.
    Siripassorn K, Manosuthi W, Chottanapund S, Pakdee A, Sabaitae S, Prasithsirikul W, Tunthanathip P, Ruxrungtham K, Bamrasnaradura Study Team.
    AIDS Res Hum Retroviruses; 2010 Feb 11; 26(2):139-48. PubMed ID: 20156097
    [Abstract] [Full Text] [Related]

  • 7. Outcomes of the Botswana national HIV/AIDS treatment programme from 2002 to 2010: a longitudinal analysis.
    Farahani M, Vable A, Lebelonyane R, Seipone K, Anderson M, Avalos A, Chadborn T, Tilahun H, Roumis D, Moeti T, Musuka G, Busang L, Gaolathe T, Malefho KC, Marlink R.
    Lancet Glob Health; 2014 Jan 11; 2(1):e44-50. PubMed ID: 25104635
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Antiretroviral treatment failure predicts mortality in rural Tanzania.
    Pettersen PS, Brox IK, Naman E, Bruun JN, Dyrhol-Riise AM, Trøseid M, Johannessen A.
    Int J STD AIDS; 2015 Aug 11; 26(9):633-9. PubMed ID: 25122578
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Conservation of first-line antiretroviral treatment regimen where therapeutic options are limited.
    Orrell C, Harling G, Lawn SD, Kaplan R, McNally M, Bekker LG, Wood R.
    Antivir Ther; 2007 Aug 11; 12(1):83-8. PubMed ID: 17503751
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Adherence to antiretroviral therapy for HIV in sub-Saharan Africa and Asia: a comparative analysis of two regional cohorts.
    Bijker R, Jiamsakul A, Kityo C, Kiertiburanakul S, Siwale M, Phanuphak P, Akanmu S, Chaiwarith R, Wit FW, Sim BL, Boender TS, Ditangco R, Rinke De Wit TF, Sohn AH, Hamers RL.
    J Int AIDS Soc; 2017 Mar 03; 20(1):21218. PubMed ID: 28362063
    [Abstract] [Full Text] [Related]

  • 14. Switching to second-line antiretroviral therapy in resource-limited settings: comparison of programmes with and without viral load monitoring.
    ART-LINC of IeDEA Study GroupInstitute of Social and Preventive Medicine (ISPM), University of Bern, Bern, Switzerland., Keiser O, Tweya H, Boulle A, Braitstein P, Schecter M, Brinkhof MW, Dabis F, Tuboi S, Sprinz E, Pujades-Rodriguez M, Calmy A, Kumarasamy N, Nash D, Jahn A, MacPhail P, Lüthy R, Wood R, Egger M.
    AIDS; 2009 Sep 10; 23(14):1867-74. PubMed ID: 19531928
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Predictors of failure of first-line antiretroviral therapy in HIV-infected adults: Indian experience.
    Rajasekaran S, Jeyaseelan L, Vijila S, Gomathi C, Raja K.
    AIDS; 2007 Jul 10; 21 Suppl 4():S47-53. PubMed ID: 17620752
    [Abstract] [Full Text] [Related]

  • 18. Incidence, risk factors and causes of death in an HIV care programme with a large proportion of injecting drug users.
    Spillane H, Nicholas S, Tang Z, Szumilin E, Balkan S, Pujades-Rodriguez M.
    Trop Med Int Health; 2012 Oct 10; 17(10):1255-63. PubMed ID: 22863110
    [Abstract] [Full Text] [Related]

  • 19. Evaluation of treatment outcomes for patients on first-line regimens in US President's Emergency Plan for AIDS Relief (PEPFAR) clinics in Uganda: predictors of virological and immunological response from RV288 analyses.
    Crawford KW, Wakabi S, Magala F, Kibuuka H, Liu M, Hamm TE.
    HIV Med; 2015 Feb 10; 16(2):95-104. PubMed ID: 25124078
    [Abstract] [Full Text] [Related]

  • 20. Marginal Structural Models to Assess Delays in Second-Line HIV Treatment Initiation in South Africa.
    Rohr JK, Ive P, Horsburgh CR, Berhanu R, Shearer K, Maskew M, Long L, Sanne I, Bassett J, Ebrahim O, Fox MP.
    PLoS One; 2016 Feb 10; 11(8):e0161469. PubMed ID: 27548695
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.